Quantcast

Latest severe asthma Stories

2014-05-06 08:32:46

TORONTO, May 6, 2014 /CNW/ - On the occasion of World Asthma Day, the Asthma Society of Canada released the first-ever patient study of Severe Asthma in Canada. The study, Severe Asthma: The Canadian Patient Journey, takes an in-depth look at the personal, social, medical and economic burden of Severe Asthma in Canada. Severe Asthma (SA), a more severe form of asthma and a greater threat to life, impacts the health and economic well-being of between 150,000 and 250,000 Canadians....

2014-05-01 12:28:46

Reduction in Exacerbations Remains the Top Driver of Physician Prescribing Choice in Moderate to Severe Asthma, According to Findings from Decision Resources Group BURLINGTON, Mass., May 1, 2014 /PRNewswire/ -- Decision Resources Group finds that 90 percent of surveyed U.S. payers indicated a willingness to pay a premium-price for a novel therapy with substantially greater improvements in reducing exacerbations than Genentech/Novartis's Xolair in the treatment of severe asthma. Surveyed U.S....

2014-03-01 12:20:30

For U.S. Media Only RIDGEFIELD, Conn., March 1, 2014 /PRNewswire/ -- Boehringer Ingelheim today presented data from Phase 3 studies of tiotropium delivered via the Respimat(®) inhaler in mild, moderate and severe asthma patients at the 2014 American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting in San Diego. Tiotropium is being studied to determine its efficacy and safety in treating asthma patients and is not currently approved for this indication. The first results...

2014-02-27 16:29:07

Bronchial Thermoplasty is the first non-drug, FDA approved therapy for severe asthma CHICAGO, Feb. 27, 2014 /PRNewswire-USNewswire/ -- Like millions of people, Jeannine Childs suffers from asthma. But unlike most, her asthma was debilitating. For years she struggled with wheezing, shortness of breath and fits of coughing so severe that they often landed her in the hospital. Nothing was really working - not lifestyle changes, not medications. "It was awful, I'd have these episodes and I'd have...

2014-01-29 16:28:39

Study Does Not Meet Primary Endpoint SOUTH SAN FRANCISCO, Calif., Jan. 29, 2014 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the completion of the randomized, double-blind placebo-controlled Phase 2 study of KB003, its anti-GM-CSF monoclonal antibody (mAb), in patients with severe asthma. While the study showed that KB003 was generally safe and well tolerated, it did not meet its primary clinical endpoint of improvement in FEV(1) (a measurement of pulmonary...

2014-01-20 12:24:00

LONDON, Jan. 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth Summary GBI Research, a leading business intelligence provider, has released its latest research report, "Asthma Therapeutics Market to 2019 -...

2013-12-12 10:33:22

A new guideline has provided an updated definition of severe asthma along with new recommendations for treating the condition. Produced by a joint task force of the European Respiratory Society and the American Thoracic Society, the guideline is published online today (12 December 2013) in the European Respiratory Journal. Although severe asthma is estimated to account for less than 10% of all asthmatics, these patients have the greatest burden and require a disproportionate amount of...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'